Matrix-M™ adjuvant elicits strong humoral and cellular immune responses in clinical influenza trials

Matrix-MTM (saponin based adjuvant) is not equivalent to or synonymous with: – ISCOMs (or "classical" ISCOMs) – MATRIX / ISCOMATRIXTM – CSL Ltd With 40 nm particles stabilized with cholesterol and phosphplipid, reduced reactogenicity vs previous saponin adjuvants, balanced Th1/Th2 stimulation of antibody and cellular response, and confirmed efficacy and safety in animals and humans; this really is an exciting …